News
Shoppers in the U.S. are continuing their boycotts against retailers like Target and Walmart. Here's why they are boycotting.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $629.44, with a ...
When she left a career in publicity to manage influencers, “I was literally making it up as we went,” she says. “It was just ...
The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching ...
Baird lowered the firm’s price target on Thermo Fisher (TMO) to $603 from $660 and keeps an Outperform rating on the shares. The firm updated ...
1d
Zacks Investment Research on MSNRobust Specialty Diagnostics Segment Likely to Aid TMO's Q1 EarningsThermo Fisher Scientific Inc. TMO is slated to release first-quarter 2025 results on April 23, before market open. Thermo ...
Bernstein lowered the firm’s price target on Thermo Fisher (TMO) to $585 from $690 and keeps an Outperform rating on the shares. With tariffs, ...
Thermo Fisher Scientific is mixing things up with its new 5L DynaDrive Single-Use Bioreactor, aiming to elevate bioprocessing game plans. This move, paired with a collaboration with NSG BIO in ...
Fisher on Wednesday said the “obvious target” for him to hit, if elected, is to beef up the Office of the Attorney General’s prosecution division. “The prosecution division right now ...
Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a ...
Though Ken Fisher concedes there are no certainties in the market, he points to a clear directional relationship ... The ...
Ken Fisher, the billionaire investor known for mixing value investing with a spicy contrarian streak, is betting on UnitedHealth Group as a defensive stock darling. Fisher’s fund holds a $1.73 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results